- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01642459
The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.
May 19, 2015 updated by: Dongliang Zhang, MD
The Outcomes of Arteriovenous Fistula (AVF) Cannulated From Different Direction in Maintenance Hemodialysis Patients.
The investigators hypothesis that aneurysms and stenoses will be decreased if the direction of inserted arterial needle were same as the direction of blood flow, when compared to the opposite direction puncture.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Native arteriovenous fistula (AVF) is the preferred access for hemodialysis, and cannulation technique is very important factors affect the outcomes of AVF.
Rope-ladder cannulation is one kind of the standard puncture techniques which is used commonly in maintenance hemodialysis (MHD) patients.
There are many complications for rope-ladder cannulation, such as venous aneurysm and vascular stenosis, which may induce AVF dysfunction.
For the venous outflow way, there always be aneurysm followed by stenoses at the sites of needle connected with the arterial line in rope-ladder cannulation patients.
The investigators hypothesis that the directions of inserted arterial needles should affect the AVF outcomes.
The present prospective study will compare the outcomes of AVF between the puncture direction at arterial needle sites same as blood flow and opposite to blood flow.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100050
- Beijing Friedship Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- MHD patients with autogenous AVF.
- Newly setup AVF in 3 months.
- Fore- or Upper arm AVF.
- Flow of >800ml/min detected by using the ultrasound dilution technique.
Exclusion Criteria:
- AVF after neoplasty.
- Arteriovenous grafts.
- Anticipated live time less than one year.
- Patients whose concurrent illnesses, disability, or geographical residence would hamper attendance at required study visit.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Same direction cannulation
The inserted direction of arterial needle is same as the direction of blood flow.
|
The puncture direction of the arterial needle is same as the blood flow in every hemodialysis session.
|
ACTIVE_COMPARATOR: Opposite direction cannulation
The inserted direction of arterial needle is opposite to the direction of blood flow.
|
The puncture direction of the arterial needle is opposite to the blood flow in every hemodialysis session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of AVF aneurysm and stenosis.
Time Frame: 12 months
|
Compare the prevalence of AVF aneurysm and stenosis between two groups during 12 months.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportions of AVF dysfunction in different groups.
Time Frame: 12 months
|
Compare the proportions of AVF dysfunction between two groups during 12 months.
|
12 months
|
The size of venous aneurysm.
Time Frame: 12 months
|
Measure the maximum size of venous aneurysm by using ultrasonography at month 12.
|
12 months
|
Diameter of venous stenosis.
Time Frame: 12 months
|
Measure the minimum diameter of venous stenosis by ultrasonography at month 12.
|
12 months
|
Percentages of unsuccessful cannulations.
Time Frame: 12 months
|
Unsuccessful cannulations include mis-cannulation, cannulation ease, hematoma, more than once cannulation at arterial site.
|
12 months
|
Events of AVF obstruction.
Time Frame: 12 months
|
AVF obstruction and the following treatments as central venous catheters and interventions will be recorded and compared between two groups during 12 months.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Dongliang Zhang, Doctor, Kidney Disease Faculty of Capital Medical University
- Study Director: Wenying Cui, Bachelor, Nephrology Department of Beijing Friendship Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (ACTUAL)
April 1, 2013
Study Completion (ACTUAL)
April 1, 2013
Study Registration Dates
First Submitted
July 12, 2012
First Submitted That Met QC Criteria
July 13, 2012
First Posted (ESTIMATE)
July 17, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
May 20, 2015
Last Update Submitted That Met QC Criteria
May 19, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-0107
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arteriovenous Fistula
-
Medtronic EndovascularCompletedFistula | Arteriovenous Fistula | Arteriovenous Fistula Stenosis | Arteriovenous Fistula OcclusionNew Zealand, United States, Japan
-
MedtronicRecruitingFistula | Arteriovenous Fistula | Arteriovenous Fistula Stenosis | Arteriovenous Fistula OcclusionUnited States
-
Hospital General Universitario Gregorio MarañonSpanish Society of NephrologyCompletedArteriovenous Fistula Stenosis | Arteriovenous Fistula ThrombosisSpain
-
Ai PengRecruitingArteriovenous Fistula Flow Monitoring | Early Detection of Complications of Arteriovenous Fistula | VoiceprintChina
-
Rennes University HospitalTerminatedStenosis of Arteriovenous Dialysis FistulaFrance
-
Fundación Pública Andaluza Progreso y SaludCompletedArteriovenous Fistula Renal Dialysis Devices ObstructionSpain
-
Centre hospitalier de l'Université de Montréal...Biotronik Canada IncCompletedArteriovenous Graft | Arteriovenous FistulaeCanada
-
Henry Ford Health SystemAnalogic CorporationCompletedArteriovenous Fistula, CannulationUnited States
-
National Taiwan University HospitalCompletedArteriovenous Fistula OcclusionTaiwan
-
Acotec Scientific Co., LtdCompleted
Clinical Trials on Same direction cannulation
-
Ajou University School of MedicineCompletedGastric CancerKorea, Republic of
-
Jessa HospitalNot yet recruiting
-
Ajou University School of MedicineCompleted
-
Azienda Usl di BolognaNiguarda Hospital; Catania Hospital GastroenterologyCompletedBiliary Tract DiseasesItaly
-
St. Jude Children's Research HospitalCompletedCannulationUnited States
-
Microvention-Terumo, Inc.CompletedIntracranial AneurysmsUnited States, Japan
-
Medical University of GdanskCompleted
-
Hospital of South West JutlandKolding SygehusActive, not recruitingEnd-stage Renal Disease (ESRD)Denmark
-
University Hospital, MontpellierRecruitingArteriovenous Fistula CannulationFrance